Sensex Opens Above 34,000, Nifty Trades Flat; Reliance Comm Surges 20%

Sun Pharmaceutical Industries said that the US FDA has accepted a new drug application, filed by its wholly owned subsidiary, for OTX-101 (cyclosporine A, ophthalmic solution) 0.09%, a novel nanomicellar formulation of cyclosporine A 0.09% in a clear, preservative-free aqueous solution.

OTX-101 is now under review for approval by the US FDA, marking an important developmental milestone for Sun Pharma’s dry eye candidate, it added. The stock gained 2 percent.

Glenmark Pharmaceuticals Inc., USA has received final approval from the United States Food & Drug Administration for Norethindrone Acetate and Ethinyl Estradiol tablets USP and Ferrous Fumarate tablets, 1 mg/20 mcg, the generic version of Minastrin 1 24 Fe tablets, of Allergan Pharmaceuticals International.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory